# L-carnitine and Coenzyme Q10 in Relation to the Oxidative Stress, Antioxidant Enzymes Activities, Inflammation, and the Risk of Coronary Artery Disease

> **NCT01819701** · PHASE2,PHASE3 · COMPLETED · sponsor: **Taichung Veterans General Hospital** · enrollment: 47 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DIETARY_SUPPLEMENT:** LC-1000
- **DIETARY_SUPPLEMENT:** LC-2000
- **DIETARY_SUPPLEMENT:** Q10-150
- **DIETARY_SUPPLEMENT:** Q10-300
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01819701
- **Lead sponsor:** Taichung Veterans General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2014-02
- **Final completion:** 2014-02
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2014-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01819701

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01819701, "L-carnitine and Coenzyme Q10 in Relation to the Oxidative Stress, Antioxidant Enzymes Activities, Inflammation, and the Risk of Coronary Artery Disease". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01819701. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*